Icosavax_Logo.jpg
Icosavax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 02, 2021 16:01 ET | Icosavax, Inc.
SEATTLE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Firm_Logo_November_2020 (2).jpg
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Ocugen, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – OCGN
July 29, 2021 11:07 ET | The Rosen Law Firm PA
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and...
emergent logo.jpg
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
July 29, 2021 07:25 ET | Emergent BioSolutions
GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) is allowing Emergent’s Bayview...
BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent
July 26, 2021 10:00 ET | BioNTech SE
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022BioNTech is evaluating sustainable mRNA vaccine production capacities...
BioNTech gibt Update zu Entwicklungsplänen für nachhaltige Lösungen gegen Infektionskrankheiten auf dem afrikanischen Kontinent
July 26, 2021 10:00 ET | BioNTech SE
BioNTech will den ersten mRNA-basierten Impfstoff zur Malaria-Prävention entwickeln und plant den Start einer klinischen Studie bis Ende 2022 BioNTech prüft nachhaltige Lösungen für...
CMMB, 81 Global Humanitarian and Faith-Based Organizations Call on Biden Administration to Provide Equitable Global Vaccine Distribution
July 26, 2021 08:00 ET | Catholic Medical Mission Board
NEW YORK, NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Catholic Medical Mission Board (CMMB) joined 81 humanitarian and faith-based organizations addressing health, social, and economic challenges...
Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
July 23, 2021 06:45 ET | BioNTech SE
Dose deliveries for new order expected to occur from October 2021 through April 2022 NEW YORK AND MAINZ, GERMANY, July 23, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)...
Pfizer und BioNTech beliefern US-Regierung mit 200 Millionen weiteren COVID-19-Impfstoffdosen, um den weiteren Impfstoffbedarf der USA zu decken
July 23, 2021 06:45 ET | BioNTech SE
Zusätzliche Dosislieferungen sollen von Oktober 2021 bis April 2022 erfolgen NEW YORK, USA und MAINZ, Deutschland, 23. Juli 2021 - Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE...
Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
July 21, 2021 07:15 ET | BioNTech SE
NEW YORK and MAINZ, GERMANY, July 21, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as...
Pfizer und BioNTech geben Zusammenarbeit mit Biovac zur Herstellung und Auslieferung von COVID-19-Impfstoffdosen in Afrika bekannt
July 21, 2021 07:15 ET | BioNTech SE
NEW YORK und MAINZ, DEUTSCHLAND, 21. Juli 2021 — Pfizer Inc. (NYSE: PFE, „Pfizer“) und BioNTech SE (Nasdaq: BNTX, „BioNTech“) gaben heute die Unterzeichnung einer Absichtserklärung mit dem in Kapstadt...